Kenneth Pienta, MD
Enriched profileProfessor of Urology; Director of Innovation and Strategy, The Brady Urological Institute; Co-Director, Prostate Cancer Research Program, Johns Hopkins University School of Medicine · Johns Hopkins University School of Medicine
Kenneth Pienta is Professor of Urology; Director of Innovation and Strategy, The Brady Urological Institute; Co-Director, Prostate Cancer Research Program, Johns Hopkins University School of Medicine at Johns Hopkins University School of Medicine. OpenAlex indexes 1,401 publications with 84,965 citations (h-index 142); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Medical Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Kenneth Pienta, MD, is Professor of Urology at Johns Hopkins University School of Medicine. The public record shows 1,401 publications with 84,965 citations (h-index 142), centered on Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer Cells and Metastasis. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 3 companies, 5 NIH-funded awards (2012–2025).
- Most recent indexed publication: 2026 · bioRxiv
- Top research focus: Prostate Cancer Treatment and Research
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 59 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 545.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
Sponsor: Progenics Pharmaceuticals, Inc.
Industry payments
Updated 27 Aug 2026
3 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20232 payments
- PFIZER INC.Program year20224 payments$10,200openpaymentsdata.cms.gov ↗
- Astellas Pharma IncProgram year20212 payments
NIH funding
Updated 27 Aug 2026
5 NIH research awards on record, funded 2012–2025 per NIH RePORTER. The latest:
- Project 1: Polyploid giant cancer cells are central actuators of tumorigenesis, skeletal metastasis, and therapeutic resistance
University of Michigan at Ann Arbor
FY2024$135,264P01CA093900
Congress activity
Updated 27 Aug 2026
154 congress contributions (2005–2025) across AACR, ASCO, ASTRO, SABCS per OpenAlex. The most recent:
- Abstract 1508: Therapy resistant cancer cells containing stress granules display signatures of oxidative stress
AACR Annual Meeting
AACR2025Co-author - Abstract 375: Cancer cells may utilize centrosome amplification to promote survival as a response to chemotherapeutic stress
AACR Annual Meeting
AACR2025Co-author - Abstract 5393: Cancer cells surviving chemotherapy reprogram glucose and glutamine metabolism to combat oxidative stress
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- ExposoGraph: An Interactive Platform for Carcinogen Bioactivation and Detoxification Pathway Visualization.
Medical oncology (Northwood, London, England)
Article2026 - Reply to Compton et al.: Another paradoxical misunderstanding.
Proceedings of the National Academy of Sciences of the United States of America
Article2026
Most-cited works
by citation count (OpenAlex)- 01Recurrent Fusion of <i>TMPRSS2</i> and ETS Transcription Factor Genes in Prostate CancerArticle3,876 citations2005
- 02Integrative Clinical Genomics of Advanced Prostate CancerArticle3,680 citations2015
- 03The polycomb group protein EZH2 is involved in progression of prostate cancerArticle2,713 citations2002
- 04The mutational landscape of lethal castration-resistant prostate cancerArticle2,601 citations2012
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/kenneth-pienta-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/ken-pienta-9951131a
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Kenneth-Pienta
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
curtco.com/mwsp-23-ken-pienta
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →curtco.com ↗ - Other
pcf.org/our-work/scientific-leadership/scientific-advisory-board/kenneth-pienta-md
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
- Chairperson
Scientific Advisory Board, Prostate Cancer Foundation
- Member
Editorial Board, Cancer and Metastasis Reviews
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Awards & honors
honors on the public record- AACR Team Science Award (2007)
first annual recipient, for group discovery of fusion genes in prostate cancer
2007provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pcf.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hopkinsmedicine.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cuebiopharma.gcs-web.com ↗
Media & interviews
press, podcasts and appearances- Podcast guest
"Pinning Down Prostate Cancer" (Johns Hopkins Series Part 2), Medicine, We're Still Practicing, Episode 23
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →curtco.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine
Constantine Lyketsos, MD
Johns Hopkins University School of Medicine